Introduction
The majority of immunotherapy-based gene therapy protocols consist of ex vivo gene transfer of cytokines or co-stimulatory molecules like GM-CSF and CD80 in tumor cells. Modified cells are irradiated before reinjection into patients in order to prevent further in vivo growth. In acute leukemia, irradiation seems mandatory because ex vivo transduced leukemic cells would be reinjected into patients in complete remission. Few studies have reported the effect of irradiation on transgene expression. Irradiation after gene transfer in mouse leukemic models has produced variable effects. Nakazaki et al reported that injection of living CD80-transduced WEHI-3B leukemic mouse cells could stimulate immune protection against subsequent injection of wild-type cells, but the injection of irradiated CD80-transduced cells did not. 1 However, other groups demonstrated in different mouse leukemic models that irradiated CD80-transduced cells could have a therapeutic effect. [2] [3] [4] It has been suggested that these discrepancies could be related to the different mouse model used and impairment of antigen-presenting properties of the target cell by irradiation; however, no data about in vitro transgene expression after irradiation and before reinjection are available. In addition, effects of g-irradiation on transgene expression have not been investigated in a primary culture of human leukemic cells, due to the lack of an efficient vector. We recently described the dramatic enhancement of gene transfer efficiency in a primary culture of myeloid leukemic cells using the modified AdZ.F(pK7) adenovirus. 5 This new vector system might allow ex vivo gene transfer protocols in acute leukemia, but one of the prerequisites of those protocols is maintaining a sustained transgene expression even after cell irradiation. In leukemic cell lines transduced with plasmids or retroviruses and in primary culture of human leukemic cells transduced with the AdZ.F(pK7) retargeted adenoviral vector, we investigate the effect of irradiation on expression of a reporter gene and transgene of potential therapeutic interest in acute leukemia.
Results

Transgene expression in leukemic cell lines
A dramatic increase in GM-CSF production after girradiation was observed in WEHI-3B-PLNC/GM-CSF cells where the GM-CSF cDNA was under the control of a CMV promoter in the retroviral vector PLNCX (P¼0.0042, Student's t-test) (Figure 1a ). Murine DA1-3b leukemic cells transfected by electroporation with the PCDNA3/GM-CSF plasmid showed an eight-fold increase of GM-CSF production after 100 Gy g-irradiation (Figure 1b) . DA1-3b cells transfected with CD80 or b-galactosidase transgene under the control of a CMV promoter also showed increase of expression in flow cytometry after g-irradiation, related, as observed by Northern blot analysis, to an increase of transgene mRNA ( Figure 2 ). Irradiation at 25 Gy of a WEHI-3B leukemic myelomonocytic cell line transduced with AdZ.F(pK7) adenoviral vector carrying b-galactosidase transgene under the control of a CMV promoter also induced increased b-galactosidase protein expression ( Figure 3) .
Murine DA1-3b/PCDNA3/LacZ cell line showed both increased percentage of FDG-positive cells and fluorescence intensity by flow cytometry after g-irradiation in a dose-dependent manner (Figure 4a ). Human leukemic cell line HL60 transduced with PCDNA3/LacZ or pSV/ LacZ plasmids showed enhancement of b-galactosidase level expression in a dose-dependent manner when the transgene was under the control of CMV promoter, but a decrease when placed under SV40 promoter (P¼0.01) (Figure 4b ). Time course analysis of b-galactosidase expression in DA1-3b cell line stably transduced with PCDNA3-b-Gal plasmid showed sustained expression both in irradiated and non-irradiated cells. However, at g-Irradiation enhances transgene expression R Vereecque et al day 7 cell viability of irradiated cells analysed by blue dye exclusion assay was below 10% ( Figure 5 ). As generation of oxygen species has been described as an essential mechanism of radiation-induced transcriptional effects, we compared the effects of oxidative stress and irradiation on transgene expression in DA1-3b-PCDNA3/LacZ, DA1-3b-PCDNA3/CD80 and WEHI-3B-PCDNA3/CD80 cell lines. Oxidative stress enhanced transgene expression in the same proportion as irradiation (P¼0.007, Student's t-test) (Figure 6a) . Addition of N-acetyl-L-cysteine (NAC), an anti-oxidant agent, inhibited both irradiation and oxidative stress transgene overexpression (P¼0.009, Student's t-test) ( Figure 6 ). As the cesium irradiator may produce heat, we also analysed if heat shock induced transgene overexpression in DA1-3b-PCDNA3/LacZ cells. No significant difference could be observed (Figure 7a ). Semi-quantitative RT-PCR analysis showed p65 NF-kb increased expression in DA1-3b-PCDNA3/LacZ cells after irradiation, but not after heat shock compared to non-irradiated cells (Figure 7b ).
Transgene expression in primary cultured AML cells
Among the four AML samples transduced with the AdZ.F(PK7) adenoviral vector at an MOI of 100 pfu/cell, three showed b-galactosidase expression in 90, 92, and 100% of AML cells 72 h after transduction when tested with X-Gal staining according to our previous results with this vector. 5 One sample showed only 60% AML cells positive with X-Gal staining. gIrradiation at 25 Gy resulted in a modest increase of percentage of X-gal-positive cells and strong increase of intensity of X-gal staining in three samples (Figure 8a ) reflected by the significantly (P¼0.03, Student's t-test) higher number of black cells after irradiation as shown in Figure 8b .
Transgene expression in syngeneic mice
In order to validate in vivo the data obtained in vitro, we injected subcutaneously 10 C3H/HeJ mice with syngeneic 25 Gy g-irradiated or control DA1-3b-PCDNA3/ LacZ and DA1-3b-PCDNA3/GM-CSF cells. FDG analysis showed a significant (P¼0.01, paired t-test) increase of b-galactosidase expression in g-irradiated DA1-3b-PCDNA3/LacZ at days 2 and 5 post-injection ( Figure 9a ). Non-irradiated cells had also increased expression in vivo compared to DA1-3b-PCDNA3/LacZ cells in vitro. Real-time PCR analysis of GM-CSF mRNA 
Discussion
Over the past 10 years, progress in the field of gene therapy has been achieved by development of new viral or non-viral vectors. In most studies, only transfer rates, vector tropisms, or transgene effects in animal models were considered. Effect of irradiation on transduced cells was rarely, if ever, investigated. However, almost all ex vivo gene transfer protocols require lethal irradiation of transduced cells before reinjection into the patients to prevent further in vivo growth. We observed in this report that lethal doses of irradiation enhanced transgene expression in leukemic cell lines and primary cultured AML cells. Moreover, we also observed in vivo enhanced GM-CSF and b-galactosidase transgene expressions in irradiated leukemic cells injected subcutaneously in mice. This effect was observed with various vector systems including plasmid electroporation, retroviruses, and adenoviruses, when transgenes were under the control of a CMV promoter, but not with an SV40 promoter. Northern blot analysis also suggested that this increase of expression was the result of increased transgene mRNA expression. girradiation has been reported to enhance transcription of various genes including those involved in cell cycle arrest and DNA repair like p53. p53 expression peaked after UV exposure and maintained transgene expression when the transgene promoter included a fixation site to p53 but not when SV40 promoter was used. 6 Enhancement of transgene expression observed with CMV promoters could be explained by over-expression of NF-kB after irradiation, which seems to mediate various gene-induced overexpressions.
7-9 Lö ser et al showed that g-Irradiation enhances transgene expression R Vereecque et al NF-kB is involved in CMV minimal promoter activation. 10 We also observed that oxidative stress enhanced transgene expression. Cellular effects of oxidative stress are mediated at least in part by activation of NF-kB. [11] [12] [13] Moreover, addition of NAC, a thiol anti-oxidant known as an NF-kB activation inhibitor, reduced in our experiments both irradiation and oxidative stress transgene overexpression. We also observed upregulation of the p65 NF-kB (RelA) subunit in irradiated cells. Thus, it seems likely that activation of NF-kB mediates transgene overexpression in leukemic cells.
We have previously reported neoexpression of CD80 in primary cultured AML cells after irradiation and another group described the same effect in tumor cell lines after irradiation and oxidative stress. 14, 15 Thus, irradiation profoundly alters the pattern of expression of transduced and untransduced cells. In our experiments, enhancement of expression occurred with a reporter gene and genes with potential therapeutic interest in acute leukemia including secreted (GM-CSF) and cell surface molecules (CD80). Time course analysis of transgene expression in vitro after irradiation showed that expression enhancement lasted one week. We also observed in vivo increased GM-CSF and b-galactosidase transgene expression 120 h after injection of irradiated leukemic cells. As tumor cells transduced with genes designed to induce a strong immune response are unlikely to survive in vivo more than one or two weeks, irradiation of modified cells would interfere during most of the lifetime of modified cells into the recipient organism. This would probably modify the immune response and it would be important to measure expression of the transgene before but also after irradiation in animal experiments and clinical trials of cancer cell vaccines.
We have previously shown that primary cultured leukemic cells can be efficiently transduced ex vivo using retargeted adenoviral vectors. 5 Thus, leukemic cells could be collected at diagnosis of the disease, transduced ex vivo with appropriate genes, irradiated, and reinfused in the patient in order to induce an anti-leukemic immune response. This whole cell vaccine approach in acute leukemia has many advantages: leukemic cells are easy to collect, culture, and freeze; in addition, most patients with acute leukemia achieve complete remission after conventional chemotherapy with a state of minimal residual disease that could potentially be eradicated by the immune response induced by a gene therapy protocol. We and other groups showed in mouse leukemic models that injection of irradiated leukemic cells transduced with various genes including CD80 and GM-CSF are able to induce an immune response against leukemia. [2] [3] [4] Our data, showing absence of a deleterious effect of irradiation on transgene expression in transduced leukemic cells, answers one of the prerequisites to a gene therapy clinical trial in acute leukemia.
Materials and methods
AML blast cells and cell lines
Fresh cells were obtained from peripheral blood of four patients with AML classified according to French American British (FAB) criteria (1 M0, 2 M2, 1 AML post-myelodysplastic syndrome), and with greater than 90% circulating blast cells. AML cells were maintained in liquid culture in ISCOVE medium (Life Technologies, Gaithersburg, USA) supplemented with 10% FCS, 100 IU penicillin, 100 mg/ml streptomycin, 2 mmol/l L-Glutamine, 20 ng/ml human recombinant stem cell factor (SCF)(Amgen, Thousand Oaks, CA, USA), 8 ng/ml IL3 (Novartis, Basel, Switzerland), 20 ng/ml GM-CSF (Schering Plough, Levallois Perret, France) at 371C with 5% CO 2 . HL60 promyelocytic cell line, WEHI-3B murine myelomonocytic leukemic cell line obtained from American Type Culture Collection (ATCC, Rockville, MD, USA), and DA1-3b murine leukemic cell line were maintained in RPMI-1640 supplemented with 10% FCS (Life Technologies Gaithersburg, MD, USA), 100 IU penicillin, 100 mg/ml streptomycin, 2 mmol/l L-Glutamine. 16 Cells were tested for mycoplasma contamination using a mycoplasma PCR ELISA kit (Boehringer, Mannheim, Germany). 
Gene transfer
Murine DA1-3b cells were transiently transduced by electroporation with a PCDNA3 plasmid carrying GM-CSF (PCDNA3/GM-CSF) and CD80 cDNA (PCDNA3/ CD80) under the control of a CMV promoter (InVitrogen, Carlsbad, CA, USA). Murine WEHI-3B myelomonocytic cells were transduced with the PLNCX retroviral vector carrying the GM-CSF cDNA (PLNC/GM-CSF) under the control of a CMV promoter and a stable expressing clone was selected with G418 and limit dilution, or electroporated with a PCDNA3/CD80 plasmid. HL60 cell lines were transiently transduced by electroporation with PCDNA3 and pSV plasmids both carrying a b-galactosidase cDNA (PCDNA3/LacZ, PSV/LacZ) under the control of CMV or SV40 promoter, respectively. Construction of the AdZ.F(pK7) modified adenoviral vector carrying a b-galactosidase gene under the control of a CMV promoter, and primary leukemic cells transduction procedure have been described previously.
5 WEHI-3B cell line and primary cultured myeloid leukemic cells were transduced at a multiplicity of infection of 10 and 100 pfu, respectively, with the modified adenovirus AdZ.F(pK7), then the vector was washed away and cells were further cultured 72 h before transgene expression analysis.
Transduced and control DA1-3b, WEHI-3B, HL60, and primary cultured leukemic cells at 8 Â 10 5 /ml in 25 ml culture flask filled with complete medium were girradiated in a 137 cesium irradiator at the minimal lethal dose ensuring at least one week of cell viability (from 25 to 100 Gy, 172 to 688 s in irradiator, respectively). Cells were also exposed to oxidative stress and heat shock as previously described. 14, 15 Briefly H 2 O 2 was added to cultured medium at 1 mM final concentration and cells were further incubated for 18 h before transgene expression analysis. In some experiments, N-acetyl-cystein (NAC) was added at 25 mM 1 h before irradiation or oxidative stress induction to ensure inhibition of NF-kB activation. Heat shock of DA1-3b-PCDNA3/LacZ cells was performed as follows: cells were exposed to 421C for 2 h and then returned to 371C for 18 h for analysis. GM-CSF production was evaluated by 24 h incubation of 10 6 DA1-3b and WEHI-3B cells in 5-ml medium, then supernatants were harvested and GM-CSF concentration was assessed with an ELISA kit according to the manufacturer's recommendation. CD80 expression was determined by flow cytometry using the following antibodies (Pharmingen, San Diego, CA, USA): FITCconjugated rat anti-mouse CD80 (clone 1G10) and control isotypic antibodies. b-Galactosidase activity was measured with the CellProbe Gal.Galactosidase system (Coulter), according to the manufacturer's recommendations. Cells were analysed on an EPICS XL3C flow cytometry system (Coulter). Dead cells were excluded from analysis by forward and side scatter pattern. In the four primary cultured AML samples, b-galactosidase activity was evaluated with X-gal staining. Transduced AML cells were counted as black cell (intense X-gal staining), blue cell (moderate and low X-gal staining), and white cells (untransduced).
Northern blot analysis
Total RNA was isolated from living cells 48 h after irradiation, using lysis with Trizol reagent (Life technologies) followed by ethanol precipitation. Total RNA (25 mg) was loaded onto an RNA formaldehyde denaturing gel and run overnight followed by an overnight transfer to Hybond C membrane. Membranes were hybridized with murine CD80, b-galactosidase and control b-actin cDNA probes labeled with [a-32P]-dCTP (Amersham Pharmacia Biotec, Orsay, France). The intensity of specific hybridization signals was evaluated using a phosphorimager.
NF-kB RT-PCR
RNA was extracted from DA1-3b-PCDNA3/LacZ cells after heat shock or 25 Gy g-irradiation, using the RNeasy Mini kit (Qiagen, Hilden, Germany). The total RNA was reverse transcripted into cDNA using Moloney Murine Leukemia virus reverse transcriptase (Gibco-BRL, Cergy Pontoise, France). Semi-quantitative RT-PCR was performed with the following sets of primer: p65 NF-kB
16 Reactions were performed using AmpliTaq Gold (Perkin Elmer, Foster City, USA). A first step of denaturation at 951C for 10 mn was followed by 25-35 cycles of amplification (30 s at 951C, 30 s at 601C, 30 s at 721C), and by a final 10 min extension at 721C. Controls without cDNA were performed for each set of PCR reactions. PCR products (10 ml) were loaded on 2% agarose gels stained with GelStar s nucleic acid gel stain (BioWhittaker, Rockland, USA) and visualized under UV illumination directly and with a gel scan software analysis system (Bio-Print, Marne la Vallée, France). The number of cycles of amplification was increased, starting from 25, until the first appearance of p65 NF-kB PCR product.
Transgene expression in syngeneic mice
In order to analyse in vivo transgene expression, we used a technique adapted from Kowalczyk et al. 17 Murine DA1-3b-PCDNA3/LacZ and DA1-3b-PCDNA3/GM-CSF leukemic cells were g-irradiated at 25 Gy, then diluted at 2 Â 10 6 cells/ml of serum-free medium and mixed at 1:1 ratio with ice-cold Matrigel (BD Biosciences, San Jose, USA). Matrigel is liquid at low temperature, but forms a gel at 371C. Groups of 10 C3H/HeJ syngeneic mice were injected subcutaneously with 5 Â 10 6 cells at a final volume of 200 ml in the right flank of the mouse for irradiated cells and, as control, in the left flank of the same animal for non-irradiated cells. At days 2 and 5 post-injection, mice were euthanized and Matrigel infiltrates containing DA1-3b-PCDNA3/LacZ and DA1-3b-PCDNA3/GM-CSF leukemic cells were harvested by skin excision. The gel obtained was diluted in PBS and 100 IU/ml collagenase (Life Technologies) was added to release leukemic cells. Cells were filtered through Miltenyi-Biotec nylon filter (Miltenyi-Biotec, Bergisch Gladbach, Germany) and washed three times in PBS. bgalactosidase was analysed by FDG analysis, and GM-CSF mRNA expression by real-time PCR using the murine GM-CSF PDAR kit (Applied Biosystems, Foster City, USA) according to the manufacturer's recommendations. As all DA1-3b cells carry a PCDNA3/p210 BCR/ ABL plasmid, we quantified DA1-3b cells in harvested Matrigel infiltrates by BCR/ABL RNA real time PCR according to the previously published technique. 
Statistical analysis
Statistical analysis was performed with Sigma Stat 2.03. software (SPSS, Chicago, IL, USA).
